Palbociclib plus endocrine therapy significantly enhances overall survival of HR +/ HER2 ‐ metastatic breast cancer patients compared to endocrine therapy alone in the second‐line setting‐a large institutional study
Published 2022 View Full Article
Published 2022 View Full Article
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started